Company intelligence / Profile preview
MDRNA, Inc.
Bothell, Washington, United Statesmodernatx.com ↗
- Ownership
- Private
- Employees
- ~40
- Development stage
- Commercial
01
Overview
MDRNA was an early innovator in the field of RNA-based therapeutics. The company developed proprietary technologies for delivering small interfering RNAs (siRNAs) and other oligonucleotides. It advanced several preclinical programs targeting cancer and metabolic diseases but did not achieve late-stage clinical success or commercialization before rebranding as Marina Biotech in 2010. Afterward, it underwent further business transitions.
- Therapeutic areas
- OncologyMetabolic DisordersRare DiseasesInfectious Diseases
- Modalities
- RNAi therapeuticsoligonucleotides (siRNA, antisense)peptide nucleic acids; previously focused on RNA interference and related modalities
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Historical collaborations with academic institutions and biotech companies on RNAi research; no major pharma partnerships reported before transition.
Beyond the preview
Go deeper on MDRNA, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MDRNA, Inc..